The patient presents with a personal history of prostate cancer.  Initial diagnosis of prostate adenocarcinoma was established on [Date of Diagnosis] with a Gleason score of [Gleason Score] at the time of diagnosis.  The clinical stage was determined to be [Clinical Stage, e.g., TNM Stage].  Initial treatment consisted of [Treatment Description, e.g., radical prostatectomy, radiation therapy, brachytherapy, active surveillance].  Prostate-specific antigen (PSA) at diagnosis was [PSA value, e.g., X ngml].  Current PSA is [Current PSA Value, e.g., X ngml].  The patient reports [Symptoms, e.g., being asymptomatic, experiencing urinary frequency, urgency, nocturia, or erectile dysfunction]. Physical examination reveals [Findings, e.g., normal digital rectal exam, palpable nodule].  Assessment includes personal history of prostate cancer, currently [Status, e.g., in remission, with biochemical recurrence, with metastatic disease].  Plan includes [Plan, e.g., continued surveillance with PSA monitoring every [Frequency], ongoing androgen deprivation therapy, referral to oncology, imaging studies such as bone scan or CT scan].  Patient education provided regarding prostate cancer management, including discussion of potential side effects of treatment and importance of follow-up care.  Coding considerations include ICD-10 code Z85.820 for personal history of prostate cancer, and additional codes for any current symptoms, complications, or treatment.  Medical billing should reflect the evaluation and management services provided, as well as any procedures performed.